Glioblastoma Cancer Vaccine ERC1671

Known as: ERC-1671, ERC1671, Gliovac 
A cancer vaccine composed of a combination of autologous glioblastoma (GBM) tumor cells, allogeneic GBM tumor cells, generated from three different… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Phase II study of ERC1671 plus bevacizumab versus bevacizumab plus placebo in recurrent glioblastoma: interim results and correlations with CD4+ T-lymphocyte counts
AIM ERC1671 is an allogeneic/autologous therapeutic glioblastoma (GBM) vaccine - composed of whole, inactivated tumor cells mixed… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Review
2018
Review
2018
Therapeutic Immunization against Glioblastoma
Glioblastoma is the most common form of brain cancer in adults that produces severe damage to the brain leading to a very poor… (More)
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2018
2018
ATIM-28. PHASE 2 STUDY OF ERC1671 PLUS BEVACIZUMAB VS BEVACIZUMAB PLUS PLACEBO IN RECURRENT GBM INTERIM RESULTS AND CORRELATIONS WITH CD4+ T LYMPHOCYTE COUNTS
 
Is this relevant?
2017
2017
HOUT-17. A PRELIMINARY DATA REPORT ON A PHASE 2 STUDY OF ERC1671 IN RECURRENT GLIOBLASTOMA
 
Is this relevant?
2016
2016
ATIM-20. A RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED PHASE 2 STUDY OF THE ERC-1671 (GLIOVAC) VACCINE IN COMBINATION WITH BEVACIZUMAB (BEV) IN RECURRENT GBM PATIENTS: SAFETY LEAD-IN ANALYSIS
 
Is this relevant?
2015
2015
First clinical results of a personalized immunotherapeutic vaccine against recurrent, incompletely resected, treatment-resistant glioblastoma multiforme (GBM) tumors, based on combined allo- and auto…
Glioblastoma multiforme (GBM) patients have a poor prognosis. After tumor recurrence statistics suggest an imminent death within… (More)
  • table 1
  • figure 4
Is this relevant?
2015
2015
Use of ERC-1671 Vaccine in a Patient with Recurrent Glioblastoma Multiforme after Progression during Bevacizumab Therapy: First Published Report.
Glioblastoma multiforme is a highy aggressive tumor that recurs despite resection, focal beam radiation, and temozolamide… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 6
Is this relevant?
2015
2015
A personalized immunotherapeutic vaccine (Gliovac Or ERC1671) against recurrent glioblastoma multiforme (GBM)
Patients suffering from a glioblastoma multiforme (GBM) present a very poor prognostic. GBM is the most malignant glioma with a… (More)
  • table 1
Is this relevant?
2012
2012
Therapeutic brain cancer targeting by gene therapy and immunomodulation : a translational study
L. Tenenbaum, M. Pouzet, A. Stathopoulos, F. Jurysta, M. Hamdane, B. Avalosse, W. Hermens, J. Verhaagen, C. Rosenbaum, O.C… (More)
  • figure 1.1
  • figure 2.1
  • figure 2.2
  • table 2.1
  • table 3.1
Is this relevant?